GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Champions Oncology Inc (FRA:2I3) » Definitions » 12-1 Month Momentum %

Champions Oncology (FRA:2I3) 12-1 Month Momentum % : -1.32% (As of Jun. 05, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Champions Oncology 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-06-05), Champions Oncology's 12-1 Month Momentum % is -1.32%.

The industry rank for Champions Oncology's 12-1 Month Momentum % or its related term are showing as below:

FRA:2I3's 12-1 Month Momentum % is ranked better than
67.5% of 1480 companies
in the Biotechnology industry
Industry Median: -24.245 vs FRA:2I3: -1.32

Competitive Comparison of Champions Oncology's 12-1 Month Momentum %

For the Biotechnology subindustry, Champions Oncology's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Champions Oncology's 12-1 Month Momentum % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Champions Oncology's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Champions Oncology's 12-1 Month Momentum % falls into.



Champions Oncology  (FRA:2I3) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Champions Oncology  (FRA:2I3) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Champions Oncology 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Champions Oncology's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Champions Oncology (FRA:2I3) Business Description

Traded in Other Exchanges
Address
One University Plaza, Suite 307, Hackensack, NJ, USA, 07601
Champions Oncology Inc is a us-based company which is engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies.

Champions Oncology (FRA:2I3) Headlines

No Headlines